UBS Group’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$38.5K Sell
7,273
-71,743
-91% -$380K ﹤0.01% 6688
2025
Q1
$349K Buy
79,016
+61,610
+354% +$272K ﹤0.01% 4920
2024
Q4
$122K Buy
17,406
+16,445
+1,711% +$115K ﹤0.01% 5541
2024
Q3
$13.9K Buy
961
+327
+52% +$4.74K ﹤0.01% 6350
2024
Q2
$46.2K Sell
634
-1,599
-72% -$117K ﹤0.01% 5604
2024
Q1
$132K Sell
2,233
-196
-8% -$11.6K ﹤0.01% 4943
2023
Q4
$178K Buy
2,429
+1,316
+118% +$96.3K ﹤0.01% 4665
2023
Q3
$43.2K Sell
1,113
-183
-14% -$7.11K ﹤0.01% 5254
2023
Q2
$74.8K Buy
1,296
+1,121
+641% +$64.7K ﹤0.01% 5167
2023
Q1
$11.4K Sell
175
-16
-8% -$1.04K ﹤0.01% 6414
2022
Q4
$5.26K Sell
191
-360
-65% -$9.91K ﹤0.01% 8002
2022
Q3
$16K Buy
551
+210
+62% +$6.1K ﹤0.01% 6617
2022
Q2
$7K Buy
341
+60
+21% +$1.23K ﹤0.01% 7496
2022
Q1
$23K Sell
281
-155
-36% -$12.7K ﹤0.01% 6264
2021
Q4
$40K Buy
436
+51
+13% +$4.68K ﹤0.01% 6029
2021
Q3
$48K Sell
385
-379
-50% -$47.3K ﹤0.01% 5272
2021
Q2
$86K Sell
764
-228
-23% -$25.7K ﹤0.01% 4954
2021
Q1
$150K Buy
992
+381
+62% +$57.6K ﹤0.01% 4682
2020
Q4
$71K Buy
611
+298
+95% +$34.6K ﹤0.01% 4929
2020
Q3
$24K Sell
313
-421
-57% -$32.3K ﹤0.01% 5309
2020
Q2
$81K Sell
734
-364
-33% -$40.2K ﹤0.01% 4650
2020
Q1
$120K Sell
1,098
-773
-41% -$84.5K ﹤0.01% 4280
2019
Q4
$298K Buy
1,871
+476
+34% +$75.8K ﹤0.01% 4316
2019
Q3
$206K Buy
1,395
+960
+221% +$142K ﹤0.01% 4342
2019
Q2
$50K Buy
435
+220
+102% +$25.3K ﹤0.01% 5076
2019
Q1
$24K Sell
215
-201
-48% -$22.4K ﹤0.01% 5325
2018
Q4
$34K Buy
416
+78
+23% +$6.38K ﹤0.01% 5484
2018
Q3
$55K Buy
338
+327
+2,973% +$53.2K ﹤0.01% 5208
2018
Q2
$2K Buy
+11
New +$2K ﹤0.01% 6807